4.10.8.4Vertical

Metabolic & Obesity Medicine

Physicians providing medically supervised weight management.

Market snapshot

These figures describe Endocrinology & Diabetes Care (4.10.8), the segment that Metabolic & Obesity Medicine sits within — not Metabolic & Obesity Medicine on its own.

FragmentationFragmentedEstimate

Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so endocrinology is not separately sized.

Business model & economics

Revenue model

Office and chronic-care management reimbursement

Key economics

Recurring revenue
High

chronic diabetes and metabolic care

EBITDA margin
12–22%
Capex intensity
Low

Characteristics

  • Diabetes, obesity, and GLP-1 demand surging.
  • Structural shortage of endocrinologists.
  • Diabetes tech and value-based metabolic care emerging.

M&A deal context

Deal activityModerate

Who’s acquiring

  • Value-based metabolic-care platforms
  • Emerging endocrinology MSOs
  • Diabetes-care strategics

What’s driving deals

  • Diabetes and GLP-1-driven demand.
  • Endocrinologist shortage and access gaps.
  • Value-based metabolic-care models.

Find Metabolic & Obesity Medicine acquisition targets

Search Acquisera’s index for companies classified under Metabolic & Obesity Medicine (4.10.8.4) and build a targeted deal pipeline.

Search companies